The earnings call presented a positive picture overall, with strong EPS growth and significant achievements in sustainability and segment performance. However, challenges persist in the Consumer Healthcare segment, Prestige Beauty, and due to increased legal expenses. The normalization of Naloxone sales also presents a potential hurdle.

Company Guidance -

Q3 2025

During the call, Aptar provided guidance on their financial performance for the second quarter of 2025, highlighting that they exceeded the high end of their guidance range with an adjusted earnings per share of $1.66, marking an 18% increase over the prior year. The company's core sales grew by 3%, supported by strong demand in their Pharma and Closures segments, with Pharma's adjusted EBITDA margin improving by 130 basis points to 35.4%. Adjusted EBITDA for the company increased by 13% to $218 million. Despite challenges in some areas, such as Consumer Healthcare in Europe, overall demand for dispensing closures and proprietary drug delivery systems drove positive results. The company announced an acquisition to expand their capabilities in clinical trial manufacturing and is expecting third quarter adjusted earnings per share to be in the range of $1.53 to $1.61. Notably, they have been recognized as one of Time Magazine's World's Most Sustainable Companies for the second consecutive year.

Strong EPS Growth

Aptar delivered adjusted earnings per share of $1.66, an increase of 18% over the prior year quarter, exceeding the high end of their guidance range.

Pharma Segment Performance

Pharma segment showed robust core sales growth with Prescription increasing by 8%, Injectables by 9%, and Active Materials Science Solutions by 11%.

Recognition for Sustainability

Aptar was named one of Time Magazine's World's Most Sustainable Companies for the second year in a row, and was also named to CDP's Supplier Engagement Assessment A List for the 2024 disclosure cycle.

New Acquisition to Expand Capabilities

Acquired Mod3 Pharma's clinical trial manufacturing capabilities, expanding Aptar Pharma services into CDMO field supporting Phase I and Phase II GMP fill and finish services.

Closure Segment Growth

Core sales in the Closures segment increased by 7%, driven by innovation and strong demand across various product categories.

AptarGroup (ATR) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

ATR Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Oct 30, 2025	2025 (Q3)	1.57 / -	1.49	―	―	―
Jul 31, 2025	2025 (Q2)	1.59 / 1.66	1.37	21.17% (+0.29)
May 01, 2025	2025 (Q1)	1.16 / 1.20	1.26	-4.76% (-0.06)
Feb 06, 2025	2024 (Q4)	1.26 / 1.52	1.21	25.62% (+0.31)
Oct 24, 2024	2024 (Q3)	1.42 / 1.49	1.39	7.19% (+0.10)
Jul 25, 2024	2024 (Q2)	1.36 / 1.37	1.23	11.38% (+0.14)
Apr 25, 2024	2024 (Q1)	1.15 / 1.26	0.95	32.63% (+0.31)
Feb 08, 2024	2023 (Q4)	1.12 / 1.21	0.92	31.52% (+0.29)
Oct 25, 2023	2023 (Q3)	1.27 / 1.39	0.95	46.32% (+0.44)
Jul 27, 2023	2023 (Q2)	1.14 / 1.23	0.96	28.13% (+0.27)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

ATR Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Jul 31, 2025	$157.14	$141.35	-10.05%
May 01, 2025	$147.87	$151.58	+2.51%
Feb 06, 2025	$155.55	$142.35	-8.49%
Oct 24, 2024	$165.12	$167.46	+1.42%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does AptarGroup (ATR) report earnings?

AptarGroup (ATR) is schdueled to report earning on Oct 30, 2025, After Close (Confirmed).

What is AptarGroup (ATR) earnings time?

AptarGroup (ATR) earnings time is at Oct 30, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is ATR EPS forecast?

ATR EPS forecast for the fiscal quarter 2025 (Q3) is 1.57.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing